Chemoinformaics analysis of 3-(4-METHOXYPHENYL)-7-(3-METHYLBUT-2-ENOXY)CHROMEN-4-ONE
| Molecular Weight | 336.387 | nRot | 5 |
| Heavy Atom Molecular Weight | 316.227 | nRig | 1 |
| Exact Molecular Weight | 336.136 | nRing | 3 |
| Solubility: LogS | -0.606 | nHRing | 1 |
| Solubility: LogP | 1.382 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 17 |
| nHA | 4 | APOL | 51.6139 |
| nHD | 0 | BPOL | 26.1401 |
| QED | 0.567 |
| Synth | 1.952 |
| Natural Product Likeliness | 0.835 |
| NR-PPAR-gamma | 0.037 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.006 |
| CACO-2 | -4.685 |
| MDCK | 0.0000982 |
| BBB | 0.946 |
| PPB | 0.403348 |
| VDSS | 0.257 |
| FU | 0.646672 |
| CYP1A2-inh | 0.03 |
| CYP1A2-sub | 0.095 |
| CYP2c19-inh | 0.021 |
| CYP2c19-sub | 0.472 |
| CYP2c9-inh | 0.01 |
| CYP2c9-sub | 0.961 |
| CYP2d6-inh | 0.011 |
| CYP2d6-sub | 0.145 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.078 |
| CL | 8.96 |
| T12 | 0.807 |
| hERG | 0.006 |
| Ames | 0.009 |
| ROA | 0.32 |
| SkinSen | 0.292 |
| Carcinogencity | 0.076 |
| EI | 0.993 |
| Respiratory | 0.049 |
| NR-Aromatase | 0.004 |
| Antiviral | Yes |
| Prediction | 0.768388 |